Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng–Tongji cohort study

Serum alpha‐fetoprotein (AFP) is the most commonly used tumor biomarker for screening and diagnosis of primary hepatocellular carcinoma (HCC). However, the predictive effect for HCC risk is still unsatisfactory. The aim of this prospective study was to estimate whether the individual genetic correct...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Med
Autors principals: Wang, Ke, Bai, Yansen, Chen, Shi, Huang, Jiao, Yuan, Jing, Chen, Weihong, Yao, Ping, Miao, Xiaoping, Wang, Youjie, Liang, Yuan, Zhang, Xiaomin, He, Meian, Yang, Handong, Guo, Huan, Wei, Sheng
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Cancer Prevention
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6010894/
https://ncbi.nlm.nih.gov/pubmed/29696820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1481
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars